Chronic lymphocytic leukemia and prognostic models: A bridge between clinical and biological markers

Am J Hematol. 2017 Jul;92(7):E135-E137. doi: 10.1002/ajh.24755. Epub 2017 May 26.

Authors

Gianluigi Reda¹, Ramona Cassin¹, Bruno Fattizzo², Diana Giannarelli³, Veronica Mattiello², Wilma Barcellini¹, Agostino Cortelezzi²

Affiliations

¹ Hematology Unit, IRCCS Ca' Granda Ospedale Maggiore Policlinico of Milan, Milano, Italy.
² Hematology Unit, IRCCS Ca' Granda Ospedale Maggiore Policlinico and University of Milan, Milano, Italy.
³ Bio-statistical Unit, Regina Elena National Cancer Institute, Rome, Italy.

PMID: 28383110
DOI: 10.1002/ajh.24755

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Biomarkers, Tumor* / blood
Biomarkers, Tumor* / genetics
Disease-Free Survival
Female
Follow-Up Studies
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / blood
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / mortality
Male
Middle Aged
Models, Biological*
Survival Rate

Substances

Biomarkers, Tumor